Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of a Synbiotic on Intestinal Barrier Function and Microbiota Modulation in Middle-aged to Elderly Individuals With Excessive Body Weight: a Randomized, Double-blind, Placebo-controlled Study

NCT07453823 is registered in ClinicalTrials.gov with Chr Hansen - part of Novonesis as lead sponsor.

NCT NCT07453823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07453823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of a Synbiotic on Intestinal Barrier Function and Microbiota Modulation in Middle-aged to Elderly Individuals With Excessive Body Weight: a Randomized, Double-blind, Placebo-controlled Study
Lead sponsor
Chr Hansen - part of Novonesis
Phase
Not applicable
Overall status
Recruiting
Start date
March 18, 2026
Completion date
December 31, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal microbiome (focus), gastrointestinal symptoms